Research and Markets: Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment & Market Forecasts to 2016

Research and Markets: Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment & Market Forecasts to 2016

Research and Markets (http://www.researchandmarkets.com/research/43da5a/continuous_glucose) has announced the addition of GlobalData's new report "Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" to their offering.

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 provides key data, information and analysis on the global Continuous Glucose Monitoring (CGM) systems market. The report provides market landscape, competitive landscape and market trends information on the Continuous Glucose Monitoring (CGM) systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

The Global Continuous Glucose Monitoring Systems Market is Forecast to Reach $370.1m in 2016

The global Continuous Glucose Monitoring (CGM) systems market is expected to exhibit a Compound Annual Growth Rate (CAGR) of 12.8% from 2009-2016, to reach $370.1m in 2016. The increasing worldwide diabetic population is the major driver for the CGM systems market. According to the International Diabetes Federation (IDF) the global prevalence of diabetes among adults aged 20-79 years of age is 6.6% in 2010 and will increase to 7.8% by 2030. About 220 million people worldwide have diabetes and it will reach 336 million by 2030. The market opportunity is high in emerging countries as 80% of all new cases of diabetes are expected to be reported in these countries by 2025.

Also, the incidence of childhood-onset type 1 diabetes in the under 15 age group is increasing in many countries in the world. About 76,000 children aged under 15 develop type 1 diabetes annually, worldwide. The large and growing number of insulin dependent diabetes patients, specifically in the US and Western Europe, require continuous monitoring of their glucose levels. This type 1 diabetic population serves as the major patient pool for the usage of CGM systems. The increasing demand for non-invasive systems is leading to the development of new technologies which in turn will increase patient adoption of newer systems.

Scope:

• Key geographies covered include the US, Canada, the UK, Germany, China, India, and Australia.
• Annualized market revenues data from 2005 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within Continuous Glucose Monitoring (CGM) systems market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Medtronic, DexCom and Abbott Laboratories.

Key Topics Covered:

1 Table of contents

2 Introduction

3 Disease Overview

4 Continuous Glucose Monitoring (CGM) Systems - Overview

5 Continuous Glucose Monitoring Systems - Market Characterization

6 Continuous Glucose Monitoring Systems Market, by Country, Revenue ($m), 2005-2016

7 Continuous Glucose Monitoring Systems, Global, Key Company Shares

8 Key Continuous Glucose Monitoring Systems in the Market

9 Continuous Glucose Monitoring Systems Market, Pipeline Assessment

10 Global Continuous Glucose Monitoring Systems Market: - Strategic Deals Analysis

For more information visit http://www.researchandmarkets.com/research/43da5a/continuous_glucose.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716